About Conference

Conference series invite all the participants over the world to require part in ‘13th International Conference on COPD and Lungs’ to be held during October 23-24, 2023 Amsterdam, Netherlands which cover prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

COPD conference 2023 which organizes 1000+ Global events regularly is glad to welcome all the interested and enthusiastic participants across the sphere to its prestigious Conference on Pulmonology and COPD which matches to be held during October 23-24, 2023 at Amsterdam, Netherlands. COPD 2023 highlights the theme “Respiratory Rehabilitation within the COVID-19”. COPD 2023 provides an exquisite opportunity to share views, exchange knowledge and establish research collaborations & networking. The foremost aim of this conference is to exchange new scientific and clinical information within the sector of COPD bringing together among the COPD Faculty, COPD Researchers, scientists, Medical Colleges, Manufacturing Medical Devices Companies, COPD Students, and Scientists under a roof.

Why to Attend

With members from round the world focused on learning about Pulmonary, Lung and respiratory illness and its advances; this is often your best opportunity to succeed in the most important assemblage of participants from the COPD, Pulmonary, Lung, and Respiratory community. Conduct presentations, distribute information, meet with current and potential scientists, Pulmonologists this conference will encourage innovative ideas and advanced diagnostic approaches towards COPD treatment and to approach Respiratory problems thanks to Covid-19. By bringing together the pulmonary community, Organizers presenting the newest developments, and identifying unmet treatment needs, COPD-2023 hopes to accelerate research in COPD, improving patient outcomes. It'll share recent advancements and knowledge share about the Pulmonary, Critical Care Medicine, Lung, Asthma, Pneumonia and Respiratory treatment strategies. The participant companies can display their product to realize the networks and to market their upcoming new strategies and exchange the ideas for the longer term era.

Target Audience

• COPD Faculty
• COPD Students, Scientists
• Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
• Pulmonologists
• COPD Researchers
• COPD Associations and Societies
• Business Entrepreneurs
• Directors/Managers
• Young Researchers
• Pulmonology Pharma Companies
• Medical Colleges
• Manufacturing Medical Devices Companies
• Laboratory Technicians
• Pharmaceutical Companies and Industries
• Training Institutes
• Pulmonary Medicine and surgery related Companies

Session & Tracks

Track 1: Chronic Obstructive Pulmonary Disease (COPD)

Chronic obstructive pulmonary disease (COPD) is a common lung disease. Having COPD makes it hard to breathe. The most common of these diseases are emphysema and chronic bronchitis.

Chronic bronchitis is inflammation of the lining of the bronchial tubes, which carry air to and from the air sacs (alveoli) of the lungs. It's characterized by daily cough and mucus (sputum) production.

Emphysema is a condition in which the alveoli at the end of the smallest air passages (bronchioles) of the lungs are destroyed as a result of damaging exposure to cigarette smoke and other irritating gases and particulate matter.

• COPD
• Chronic bronchitis
• Emphysema

Track 2: Chronic Bronchitis

Bronchitis is an inflammation of the liner of the bronchial tubes. That’s when the air tubes in your lungs called bronchi get irritated and inflamed, and you've got coughs for a minimum of 3 months a year for two years during a row. Bronchitis may be either acute or chronic. Swelling of the tubes makes it harder for your lungs to maneuver oxygen in and CO2 out of your body.

• COPD Symptoms
• Emphysema
• Mucus

Track 3: Emphysema

Emphysema is a disease of the lungs. It occurs most frequently in smokers, but it also occurs in people that regularly inhale irritants. Emphysema destroys alveoli, which are air sacs within the lungs. The air sacs weaken and eventually break, which reduces the area of the lungs and therefore the amount of oxygen which will reach the bloodstream.

• Bronchitis
• Exhaustion
• Depression
• Fast Heartbeat

Track 4:Asthama

Asthma is a disease of the airways to the lungs. It makes breathing difficult and should make some physical activities challenging or even impossible. Asthma causes the inside walls of the airways, or the bronchial tubes, to become swollen and inflamed. Asthma can't be cured, but its symptoms are often controlled. Because asthma often changes over time, it's vital that you simply work alongside your doctor to trace your signs and symptoms and adjust your treatment as needed.

• Shortness of Breath
• Difficulty Talking
• Fatigue

Track 5: Pulmonary Arterial Hypertension

Pulmonary hypertension could also be a life-threatening condition that gets worse over time, but treatments can help your symptoms so you'll live better with the disease. In one sort of pulmonary hypertension, called pulmonary arterial hypertension (PAH), blood vessels in your lungs are narrowed, blocked or destroyed.

• Sleep Apnea
• Blood clot in the Lungs
• Congestive heart failure

Track 6: Pneumonia

Pneumonia is an infection of the lungs with a variety of possible causes. It can be a serious and life-threatening disease. It happens when an infection causes the air sacs in your lungs (your doctor will call them alveoli) to fill with fluid or pus. That can make it hard for you to inhale enough oxygen to succeed in your bloodstream.

• Contagious
• Walking Pneumonia
• Diarrhea
• Antibiotics

Track 7: Cystic Fibrosis

Cystic fibrosis (CF) may be a serious genetic condition that causes severe damage to the respiratory and digestive systems. This damage often results from a build-up of thick, sticky mucus within the organs. When mucus clogs the lungs, it can become very difficult for an individual to breathe. The thick mucus also allows for germs to thrive and multiply, which may end in infections and inflammation and sometimes results in severe lung damage and respiratory failure.

• Diabetes
• Malnutrition
• Nasal Polyps

Track 8: Coronavirus (COVID-19)

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. COVID-19 is a disease caused by SARS-CoV-2 that can trigger what doctors call a respiratory tract infection. It can affect your upper respiratory tract (sinuses, nose, and throat) or lower respiratory tract (windpipe and lungs).

• Sortness of breath
• Trouble Breathing

Track 9: Lung Cancer

Lung cancer is a type of cancer that starts in the lungs. It is commonest in males, and within the U.S., Black males are around 15% more likely to develop it than white males. People who smoke have the best risk of carcinoma, though carcinoma also can occur in people that haven't smoked.

• Bronchi
• Trachea
• Pleura

Track 10: Interventional pulmonology

Interventional pulmonology (IP) may be a rapidly growing, procedurally focused subspecialty of pulmonary medicine. Interventional pulmonology uses endoscopy and other tools to diagnose and treat conditions within the lungs and chest. Diseases which were previously almost considered as contraindications to bronchoscopy, like asthma and COPD/emphysema, can now, in selected cases, be treated endoscopically.

• Diagnostic Bronchoscopy
• COPD/Emphysema
• Rigid Bronchoscopy

Track 11: Respiratory Tract Infections

Respiratory tract infection (RTI) is defined as any communicable disease of the upper or lower tract. Most RTIs recover without treatment, but sometimes you'll got to see your GP. Upper respiratory tract infections (URTIs) include the common cold, laryngitis, pharyngitis/tonsillitis, acute rhinitis, acute rhinosinusitis and acute otitis media. Lower respiratory tract infections (LRTIs) include acute bronchitis, bronchiolitis, pneumonia and tracheitis.

• Diagnosis
• Antibiotics
• Epidemiology

Track 12: Stages & Severity on Lung Diseases

There is no formal staging system for pulmonary fibrosis. Physicians use different factors, like the ones listed below, to describe the disease as mild, moderate, severe or very severe.

• Symptoms
• Pulmonary Function Test or Lung function Test
• Six minute walk test
• A high resolution CT scan

Market Analysis

The Global Chronic Obstructive Pulmonary Disease (COPD) Market will increase to around USD 22.91 Billion by 2028 according to the publisher. Chronic inflammatory lung disease causes breathing difficulties.

It is a group of progressive lung diseases. The most common diseases are emphysema and chronic bronchitis. COPD, if left untreated, can lead to worsening respiratory infection, heart problems, and the progression of various other diseases.

COPD is commonly caused due to smoking tobacco-related products. The longer and more tobacco products an individual smokes, the greater risk of having COPD.

Worldwide Chronic Obstructive Pulmonary Disease Market will grow at a CAGR of 5.73% from 2022 to 2028

The rise in the incidence of COPD is the major contributor to the market's growth. In addition, people's lifestyle change is responsible for increasing habits like smoking and drinking.

Chronic Bronchitis will lead in Chronic Obstructive Pulmonary Disease Market

Based on type, the global COPD market is categorized into; chronic bronchitis and emphysema. The chronic bronchitis category dominates the market share of the worldwide COPD market. The reason for its dominance is the growing incidence and prevalence of chronic bronchitis worldwide, due to the rise in the consumption of cigarettes and the increase in industrialization, which results in air pollution and the release of harmful gases into the environment.